Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
-
Ann. Allergy Asthma Immunol. · Mar 1999
Randomized Controlled Trial Multicenter Study Comparative Study Clinical TrialInhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
The current stepwise approach to pharmacotherapy in the treatment of asthma includes the initiation of an inhaled corticosteroid with the addition of a long-acting inhaled bronchodilator if low dose inhaled corticosteroid fails to control asthma symptoms. ⋯ Initiation of maintenance therapy with salmeterol and fluticasone propionate in patients with asthma treated with short-acting beta2-agonists alone provides greater improvements in pulmonary function and symptom control than initiation of maintenance therapy with fluticasone propionate alone.
-
Ann. Allergy Asthma Immunol. · Mar 1999
Randomized Controlled Trial Clinical TrialDiskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Fluticasone propionate is a topically active glucocorticoid with potent antiinflammatory activity in the treatment of asthma. ⋯ Fluticasone propionate powder, administered via the Diskus or Diskhaler inhalation devices, was well tolerated and effective in the treatment of mild-to-moderate persistent asthma.